{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:20:40Z","timestamp":1792516840127,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ebiom.2024.105423","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T19:03:43Z","timestamp":1729883023000},"page":"105423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Vitiligo is associated with an increased risk of cardiovascular diseases: a large-scale, propensity-matched, US-based retrospective study"],"prefix":"10.1016","volume":"109","author":[{"given":"Alicja","family":"Fr\u0105czek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Owczarczyk-Saczonek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamant","family":"Thaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0053-4312","authenticated-orcid":false,"given":"Henner","family":"Zirpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105423_bib1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A\u00a0review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054910","article-title":"Vitiligo, from pathogenesis to therapeutic advances: state of the art","volume":"24","author":"Diotallevi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2024.105423_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijwd.2017.11.005","article-title":"Vitiligo: patient stories, self-esteem, and the psychological burden of disease","volume":"4","author":"Grimes","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1072837","article-title":"Beyond skin white spots: vitiligo and associated comorbidities","volume":"10","author":"Hu","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.ebiom.2024.105423_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jid.2021.05.022","article-title":"Immunophenotypic analysis reveals differences in circulating immune cells in the peripheral blood of patients with segmental and nonsegmental vitiligo","volume":"142","author":"Willemsen","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib6","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s13555-023-01001-2","article-title":"Comorbidity burden among patients with vitiligo in the United States: a large-scale retrospective claims database analysis","volume":"13","author":"Ezzedine","year":"2023","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ebiom.2024.105423_bib7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bjd.12166","article-title":"Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms","volume":"168","author":"Gey","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4274\/balkanmedj.2016.1005","article-title":"Increased risk of metabolic syndrome in patients with vitiligo","volume":"34","author":"Ata\u015f","year":"2017","journal-title":"Balkan Med J"},{"key":"10.1016\/j.ebiom.2024.105423_bib9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/pcmr.12941","article-title":"Support for increased cardiovascular risk in non-segmental vitiligo among Egyptians: a hospital-based, case-control study","volume":"34","author":"Azzazi","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.ebiom.2024.105423_bib10","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1111\/jdv.18936","article-title":"Lack of association between vitiligo and major adverse cardiovascular events: a population-based cohort study","volume":"37","author":"Wu","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ebiom.2024.105423_bib11","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jid.2023.02.031","article-title":"Automated mass screening for comorbidities of vitiligo using the national health insurance database","volume":"143","author":"Han","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jid.2023.07.007","article-title":"All-cause and cause-specific mortality among patients with vitiligo: a nationwide population-based study in Korea","volume":"144","author":"Ju","year":"2024","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib13","first-page":"58","article-title":"Assessing the relationship between vitiligo and cardiovascular disease risk factors","volume":"8.3","author":"Minhaj Rahman","year":"2023","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ebiom.2024.105423_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40256-015-0141-4","article-title":"Management of cardiovascular risk in patients with chronic inflammatory diseases: current evidence and future perspectives","volume":"16","author":"Lindhardsen","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ebiom.2024.105423_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105123","article-title":"Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study","volume":"103","author":"Olbrich","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2024.105423_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/VHRM.S343319","article-title":"Cardiovascular disease-associated skin conditions","volume":"18","author":"Hojman","year":"2022","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ebiom.2024.105423_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104639","article-title":"Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study","volume":"93","author":"Olbrich","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2024.105423_bib18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jaci.2018.11.030","article-title":"Atopic eczema and major cardiovascular outcomes: a systematic review and meta-analysis of population-based studies","volume":"143","author":"Ascott","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.ebiom.2024.105423_bib19","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/jdv.19328","article-title":"Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors - a population-based study","volume":"37","author":"Kridin","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ebiom.2024.105423_bib20","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1111\/jdv.18700","article-title":"Mortality in eight autoimmune bullous diseases: a global large-scale retrospective cohort study","volume":"37","author":"Boch","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ebiom.2024.105423_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies","volume":"69","author":"Elze","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ebiom.2024.105423_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/aje\/kwj047","article-title":"Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect","volume":"163","author":"Kurth","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ebiom.2024.105423_bib23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2024.105423_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jamacardio.2018.4537","article-title":"Cardiovascular risk factors associated with venous thromboembolism","volume":"4","author":"Gregson","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ebiom.2024.105423_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jamadermatol.2021.1570","article-title":"Incidence of venous thromboembolism in patients with dermatologist-diagnosed chronic inflammatory skin diseases","volume":"157","author":"Schneeweiss","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib26","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.21037\/apm-21-1738","article-title":"Prevalence of vitiligo and associated comorbidities in adults in Shanghai, China: a community-based, cross-sectional survey","volume":"10","author":"Tang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.ebiom.2024.105423_bib27","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3899\/jrheum.161121","article-title":"Evolution of risk factors for atherosclerotic cardiovascular events in systemic lupus erythematosus: a longterm prospective study","volume":"44","author":"Tselios","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib28","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s10067-022-06302-z","article-title":"Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study","volume":"41","author":"Shams-Eldin","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib29","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/bjd.12806","article-title":"Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the national skin centre","volume":"170","author":"Cai","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamadermatol.2021.5125","article-title":"Risk of all-cause mortality, cardiovascular disease mortality, and cancer mortality in patients with bullous pemphigoid","volume":"158","author":"Shen","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-4632.2011.05430.x","article-title":"Risk and predictors of cardiovascular disease in psoriasis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.autneu.2011.06.005","article-title":"Seropositive myasthenia and autoimmune autonomic ganglionopathy: cross reactivity or subclinical disease?","volume":"164","author":"Miglis","year":"2011","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.ebiom.2024.105423_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2014.03.056","article-title":"Incidence of and risk factors for sick sinus syndrome in the general population","volume":"64","author":"Jensen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ebiom.2024.105423_bib34","doi-asserted-by":"crossref","first-page":"e14803","DOI":"10.1111\/dth.14803","article-title":"Increased risk of subclinical atherosclerosis and metabolic syndrome in patients with vitiligo: a real association or a coincidence?","volume":"34","author":"Namazi","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ebiom.2024.105423_bib35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.15537\/smj.2017.4.17551","article-title":"Chronic diseases among vitiligo patients. A case control study","volume":"38","author":"Al Houssien","year":"2017","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ebiom.2024.105423_bib36","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis: JACC review topic of the week","volume":"77","author":"Garshick","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ebiom.2024.105423_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5021\/ad.2016.28.3.360","article-title":"The association between psoriasis area and severity index and cardiovascular risk factor in Korean psoriasis patients","volume":"28","author":"Ku","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1346-8138.15743","article-title":"Vitiligo: a focus on pathogenesis and its therapeutic implications","volume":"48","author":"Bergqvist","year":"2021","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.ebiom.2024.105423_bib39","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.3390\/ijms23169063","article-title":"Psoriasis and cardiometabolic diseases: shared genetic and molecular pathways","volume":"23","author":"Piaserico","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2024.105423_bib40","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3389\/fimmu.2019.03096","article-title":"IL-17A in psoriasis and beyond: cardiovascular and metabolic implications","volume":"10","author":"von Stebut","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2024.105423_bib41","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/biomedicines10071639","article-title":"Current concepts of vitiligo immunopathogenesis","volume":"10","author":"Hla\u010da","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ebiom.2024.105423_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.568447","article-title":"Autoimmunity in segmental vitiligo","volume":"11","author":"Speeckaert","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2024.105423_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.ebiom.2024.105423_bib44","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jdv.16830","article-title":"Both cardiovascular and cerebrovascular events are decreased following long-term narrowband ultraviolet B phototherapy in patients with vitiligo: a propensity score matching analysis","volume":"35","author":"Bae","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ebiom.2024.105423_bib45","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ahj.2015.02.020","article-title":"Rationale and design of the cyclosporine to ImpRove clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)","volume":"169","author":"Mewton","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ebiom.2024.105423_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:39:29Z","timestamp":1732063169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424004596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":46,"alternative-id":["S2352396424004596"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105423","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitiligo is associated with an increased risk of cardiovascular diseases: a large-scale, propensity-matched, US-based retrospective study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105423"}}